🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, pharmacokinetic, pharmac...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2020-08-31
Trial ID
NCT04494503
This is a single center, open-label, phase II study of venetoclax (ABT-199)...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-06-16
Trial ID
NCT03128879
Treatments Being Tested
The purpose of this study is to describe the 2-year retention rate of ibrut...
Status
Completed
Location
Ospedali Riuniti Di Ancona
Start Date
2018-10-30
Trial ID
NCT03720561
Treatments Being Tested
The purpose of this study is to evaluate efficacy of ibrutinib in Japanese ...
Status
Completed
Location
Anjo Kosei Hospital
Start Date
2018-05-01
Trial ID
NCT03474679
Treatments Being Tested
BTKi has become the standard treatment regimen for CLL/SLL，there is a lack ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2024-07-13
Trial ID
NCT06508684
Treatments Being Tested
This phase I trial studies the side effects and best dose of ibrutinib and ...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2014-08-13
Trial ID
NCT02159755
Treatments Being Tested
This is an open label, multi-centre, phase II study in which RR MCL patient...
Status
Active Not Recruiting
Location
Princess Alexandra Hospital
Start Date
2023-09-07
Trial ID
NCT05864742
Treatments Being Tested
Chronic graft-versus-host disease (cGVHD) affects 30 to 70% of Allogeneic H...
Status
Unknown
Location
Hospital Universitario Dr. José Eleuterio González
Start Date
2022-04-01
Trial ID
NCT05348096
Treatments Being Tested
This is a dose-escalation to determine the MTD and/or RPII for combinations...
Status
Active Not Recruiting
Location
The Cancer Center at Hackensack University Medical Center
Start Date
2015-06-18
Trial ID
NCT02446236
Treatments Being Tested
The purpose of this study is to determine the most appropriate dose for the...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2017-07-14
Trial ID
NCT03153202
Treatments Being Tested